Switch to:

Sagent Pharmaceuticals Co (SGNT)Ownership Data

Short Interest History (%)

This is the historical short interest of Sagent Pharmaceuticals Co, as measured by the Short Percentage Of Float.

Date Short Interest
February 13, 201514.45
January 30, 201516.85
January 15, 201517.18
December 31, 201414.12
December 15, 201413.98
November 28, 201412.8
November 14, 201412.55
October 31, 201411.04
October 15, 201411.65
September 30, 201412.94
September 15, 201411.98
August 29, 201411.96
August 15, 201412.51
July 31, 201414.33
July 15, 201416.31
June 30, 201413.75
June 13, 201413.46
May 30, 201413.29
May 15, 201413.23
April 30, 201414.03
April 15, 201415
March 31, 201414.02
March 14, 201412.39
February 28, 201413.61
February 14, 201412.6
January 31, 20149.32
January 15, 20147.8
December 31, 20137.96
December 13, 20136.7
November 29, 20136.52
November 15, 20136.92
October 31, 20136.92
October 15, 20136.12
September 30, 20135.7
September 13, 20137.21
August 30, 20135.69
August 15, 20135.35
July 31, 20135.41
July 15, 20136.16
June 28, 20134.91
June 14, 20135.43
May 31, 20137
May 15, 20137.13
April 30, 20135.77
April 15, 20132.61
March 28, 201311.26
March 15, 20138.84
February 28, 20139.17
February 15, 20137.8
January 31, 20137.15
January 15, 20137.53
December 31, 20127.96
December 14, 20129.17
November 30, 201211.3
November 15, 201211.32
October 31, 201211.56
October 15, 201212.08
September 28, 201212.55
September 14, 201213.91
August 31, 201213
August 15, 201214.26
July 31, 201216.5
July 13, 201220.89
June 29, 201224.1
June 15, 201223.05
May 31, 201223.8
May 15, 201224.3
April 30, 201223.01
April 13, 201222.37
March 30, 20125.26
March 15, 20125.21
February 29, 20125.31
February 15, 20125.23
January 31, 20125.05
January 13, 20124.39
December 30, 20114.49
December 15, 20114.34
November 30, 20114.18
November 15, 20113.37
October 31, 20112.96
October 14, 20112.98
September 30, 20112.4
September 15, 20112.41
August 31, 20111.91
August 15, 20111.65
July 29, 20112.17
July 15, 20111.93
June 30, 20112.13
June 15, 20110.9
May 31, 20110.15
May 13, 20110.12
April 29, 20110.13

Institutional Ownership History (%)

This the Institutional Ownership History of Sagent Pharmaceuticals CoPeter Lynch prefers to buy companies with low institutional ownership.

Date Institutional Ownership
January 31, 201582
December 31, 201479
November 30, 201475
March 31, 201497
February 28, 201498
January 31, 201498
December 31, 201397
October 31, 2013100
August 31, 201395
July 31, 201367
June 30, 201368
May 31, 201366
April 30, 201366
March 31, 201317
January 31, 201398
January 31, 201257
December 31, 201143
November 30, 201143
October 31, 201143
September 30, 201139
August 31, 201140
July 31, 201112
June 30, 20116
May 31, 20114

Insider ownership (%)

This is the historical insider ownership of Sagent Pharmaceuticals Co. It is usually better to buy companies with large insider ownership. The company insiders' interest are more aligned with external shareholders in this case.

Date Insider Ownership
January 31, 20153
December 31, 20142
November 30, 20143
October 31, 20143
September 30, 20143
August 31, 20143
July 31, 20143
June 30, 20143
May 31, 20143
March 31, 20143
February 28, 20143
January 31, 20143
December 31, 20133
November 30, 20133
October 31, 20133
September 30, 20133
August 31, 20133
July 31, 20133
June 30, 20133
May 31, 20133
April 30, 20133
March 31, 20133
January 31, 20133
November 30, 20123
October 31, 20123
September 30, 20123
August 31, 20123
July 31, 20123
June 30, 20123
May 31, 20123
April 30, 20123

Top Direct Holders

HolderPositionShares% of Shares
Outstanding
Report Date
Mr. Jeffrey YordonCEO686,0142.15%2015-02-25
Michael LogerfoChief Legal Officer48,2430.15%2015-02-25
Mr. Albert Patterson, R.Ph.N/A36,9960.12%2015-02-25
Dr. Frank Kung, PhDDirector36,9090.12%2015-02-21
Mr. Lorin DrakeCorporate VP, Sales27,902less than 0.1%2015-02-25
Jonathon M SingerN/A19,655less than 0.1%2015-02-25
James M. HusseyN/A11,058less than 0.1%2015-02-25
Robert J. FlanaganDirector9,253less than 0.1%2015-02-21
Mr. Anthony KrizmanN/A4,150less than 0.1%2015-02-21
Mary Taylor BehrensN/A4,150less than 0.1%2015-02-21

Top Fund Holders

HolderSharesReport Date% of Shares
Outstanding
% of Total
Assets Managed
Market Value
Franklin Advisers, Inc.4,388,9162014-12-3113.750.08110,206,000
Morgan Stanley AIP GP LP3,731,2922014-12-3111.6924.4293,693,000
BlackRock Fund Advisors1,903,2692014-12-315.960.0147,791,000
Vanguard Group, Inc.1,601,7272014-12-315.020.0040,220,000
Acadian Asset Management LLC1,227,7672014-12-313.850.1430,827,000
Franklin US Opportunities1,121,7212014-09-303.520.8134,885,523
Franklin Biotechnology Discovery1,050,2482014-10-313.291.2933,229,847
China Renaissance Capital Invest II GP1,012,6072013-12-313.190.0025,699,966
State Street Corp935,1072014-12-312.930.0023,485,000
Franklin Small Cap Growth Fund878,3002014-12-312.750.8122,054,113

Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK